Table 1 Patients’ characteristic
From: Deficiency of peripheral CLA+ Tregs and clinical relevance in Behcet’s syndrome
Characteristic | Data |
|---|---|
Age (year) | 40.0(32.0, 52.75) |
Sex | |
Male | 59 (55.1%) |
Female | 48 (44.9%) |
Disease duration (month) | 84.0 (24.0–180.0) |
BDCAF | 3.0 (2.0, 4.0) |
Symptom | |
oral aphthae | 102 (95.3%) |
genital ulcers | 58 (54.2%) |
pseudofolliculitis | 44 (41.1%) |
erythema nodosum | 31 (29.0%) |
arthritis | 26 (24.3%) |
uveitis | 25 (23.4%) |
gastrointestinal involvement | 23 (21.5%) |
neurological involvement | 20 (18.7%) |
parenchymal | 15 (14.0%) |
nonparenchymal | 5 (4.7%) |
arterial aneurysm | 15 (14.0%) |
fever | 13 (12.1%) |
thromboembolism | 12 (11.2%) |
Previous medications | |
glucocorticoids | 30 (27.5%) |
thalidomide | 28 (26.2%) |
colchicine | 14 (13.1%) |
azathioprine | 8 (7.5%) |
hydroxychloroquine | 6 (5.6%) |
mycophenolate mofetil | 4 (3.7%) |
calcineurin inhibitor | 4 (3.7%) |
biological agents | 4 (3.7%) |
cyclophosphamide | 2 (1.9%) |